Skip to main content

Want a detailed portfolio tracker?

Agenus (AGEN) P/E (2012 - 2026)

Agenus (AGEN) P/E from Apr 2, 2012 to Jul 21, 2026. The TTM Agenus (AGEN) P/E is 5.48. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Agenus (AGEN)

YearP/EChange
20265.48-152.44%
2025-10.45+655.58%
2024-1.38-93.63%
2023-21.73-64.85%
2022-61.81-25.47%
2021-82.93+1.26%
2020-81.90-21.87%
2019-104.82+71.01%
2018-61.29-26.99%
2017-83.96-20.87%
2016-106.10-9.25%
2015-116.92+14.36%
2014-102.24+50.38%
2013-67.99-183.79%
201281.14N/A

Comparison Agenus (AGEN) P/E with competitors

Agenus (AGEN) P/E is 5.48.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.97%
NBYStablecoin Development Corp0.00-99.92%
ENLVEnlivex Ltd0.07-98.64%
FGENFibroGen Inc0.24-95.62%
CHRSCoherus Biosciences Inc0.85-84.52%
FBIOFortress Biotech Inc0.95-82.69%
ORMPOramed Pharmaceuticals Inc1.50-72.58%
INVAInnoviva Inc3.15-42.47%
VXRTVaxart Inc3.55-35.25%
CRMDCorMedix Inc3.63-33.81%
CVACCureVac N.V.4.45-18.91%
GLPGGalapagos NV4.86-11.37%
SRPTSarepta Therapeutics Inc4.88-10.95%
ABEOAbeona Therapeutics Inc5.39-1.73%
ABUSArbutus Biopharma Corp5.60+2.07%
ZVRAZevra Therapeutics Inc5.89+7.39%
SPROSpero Therapeutics Inc6.23+13.61%
CGENCompugen Ltd6.31+15.17%
RIGLRigel Pharmaceuticals6.87+25.35%
SLXNSilexion Therapeutics Corp7.30+33.09%
OMEROmeros Corporation9.26+68.89%
AUPHAurinia Pharmaceuticals Inc9.58+74.84%
PLXProtalix BioTherapeutics Inc10.89+98.66%
ACADAcadia Pharmaceuticals Inc11.73+113.94%
TBPHTheravance Biopharma Inc12.26+123.67%
ADMAAdma Biologics Inc12.42+126.52%
HRMYHarmony Biosciences Holdings Inc13.82+152.09%
SABSSAB Biotherapeutics Inc14.14+157.85%
NAGENiagen Bioscience Inc14.82+170.29%
INCYIncyte Corp15.82+188.61%
REGNRegeneron Pharmaceuticals Inc15.86+189.24%
PBYIPuma Biotechnology Inc17.32+215.85%
CPRXCatalyst Pharmaceuticals Inc17.44+218.11%
EXELExelixis Inc17.54+219.91%
TGTXTG Therapeutics Inc18.97+245.95%
MDXGMimedx Group Inc20.55+274.89%
XOMAXOMA Royalty Corp22.87+317.26%
ARGXArgen X SE24.30+343.22%
CTMXCytomX Therapeutics Inc24.82+352.77%
XOMAOXOMA Royalty Corp25.34+362.32%
HALOHalozyme Therapeutics Inc25.62+367.41%
XOMAPXOMA Royalty Corp25.67+368.25%
VRTXVertex Pharmaceuticals Inc27.99+410.66%
RPRXRoyalty Pharma plc - Class A28.69+423.29%
SLNOSoleno Therapeutics Inc29.02+429.27%
ASNDAscendis Pharma A/S30.09+448.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91+591.56%
APLSApellis Pharmaceuticals Inc39.02+611.79%
BMRNBiomarin Pharmaceutical Inc42.21+669.99%
KRYSKrystal Biotech Inc45.34+727.12%
ONCBeiGene Ltd69.54+1168.50%
PHARPharming Group N.V.75.03+1268.56%
TECHBio-Techne Corp101.96+1759.84%
VCELVericel Corp109.92+1905.10%
ALNYAlnylam Pharmaceuticals Inc117.96+2051.82%
GMABGenmab140.29+2459.07%
TLXTelix Pharmaceuticals Ltd162.15+2857.86%
CORTCorcept Therapeutics Inc212.86+3782.77%